Substantially Reduced Incidence of Genital Warts in Women and Men Six Years After HPV Vaccine Availability in Sweden
Overview
Authors
Affiliations
Background: Between 2007 and 2011, opportunistic HPV-vaccination was available in Sweden and partially subsidized to girls aged 13-17, reaching a ∼30% overall coverage.
Methods: All Swedish women/men aged 15-44 were followed between 2006 and 2012 for condyloma. Average annual percent changes (AAPCs) in incidence were estimated.
Results: Substantial decreases were seen in women aged 15-24 from 2008-onwards (AACP-range: -8.5% to -18.5%); similar effects were seen for men aged 15-29 (AACP-range: -7.0% to -16.6%) from 2010-onwards.
Discussion: Despite low population vaccination coverage in women and no coverage in men, similar condyloma incidence reductions were observed among men and women, with delays of >1 years in men.
Gylling A, Uusi-Rauva K, Toppila I, Hiltunen-Back E Vaccines (Basel). 2023; 11(7).
PMID: 37515019 PMC: 10384701. DOI: 10.3390/vaccines11071202.
Viottini E, Albanesi B, Casabona E, Onorati R, Campagna S, Borraccino A Int J Environ Res Public Health. 2022; 19(21).
PMID: 36361087 PMC: 9656796. DOI: 10.3390/ijerph192114207.
Mo Z, Bi Z, Sheng W, Chen Q, Huang T, Li M Hum Vaccin Immunother. 2022; 18(6):2092363.
PMID: 35834812 PMC: 9746527. DOI: 10.1080/21645515.2022.2092363.
Attitudes Toward HPV Vaccination in Sweden: A Survey Study.
Wemrell M, Gunnarsson L Front Public Health. 2022; 10:729497.
PMID: 35619814 PMC: 9127737. DOI: 10.3389/fpubh.2022.729497.
Righolt C, Willows K, Kliewer E, Mahmud S PLoS One. 2022; 17(4):e0267646.
PMID: 35472093 PMC: 9041799. DOI: 10.1371/journal.pone.0267646.